INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY AND TIES-AND-UNITS-IN-THE-CLINICAL-LABORATORY-SCIENCES - VI - PROPERTIES AND UNITS IN IOC PROHIBITED DRUGS (IFCC-IUPAC RECOMMENDATIONS 1997)
H. Olesen et al., INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY AND TIES-AND-UNITS-IN-THE-CLINICAL-LABORATORY-SCIENCES - VI - PROPERTIES AND UNITS IN IOC PROHIBITED DRUGS (IFCC-IUPAC RECOMMENDATIONS 1997), Clinica chimica acta, 268(1-2), 1997, pp. 5-73
The term designating a substance being an active ingredient of a drug
may be a generic name, a nonproprietary name, a registered trade name,
a fantasy name or other. This causes difficulties in the transmission
of request and report on such substances to and from the clinical lab
oratories, and In the collating of this information from different sou
rces. The document comprises a list of properties of drugs of abuse in
biological fluids as defined by the international Olympic Committee M
edical Code for use in electronic transmission systems. Standard syste
matic names are presented with a code value for each. The coding schem
es thus prepared are accessible on Internet from C-NPU Home page addre
ss: http://inet.uni-c.dk/ similar to qukb7642 Published by Elsevier Sc
ience B.V.